Targeted Protein Degradation Market Revenue to Cross USD 7 billion by 2035

According to a recently published report by Roots Analysis, the growing degrader pipeline, technological advancements and encouraging clinical trial results are driving the targeted protein degradation market

Targeted Protein Degradation Industry Overview

The global targeted protein degradation market size was estimated to be close to USD 0.48 billion in 2024 and is expected to reach USD 7 billion by 2035, growing at a CAGR of 32% during the forecast period 2024-2035.

Over the years, the growing scientific literature and understanding of various cellular mechanisms has prompted the researchers to look out for innovative ways to use physiological proteostasis mechanisms for targeting various oncological and neurological disorders. One such approach is targeted protein degradation that involves breakdown of disease-causing proteins by altering the cellular machinery within the small molecules. Moreover, the modalities responsible for destruction of proteins are known as targeted protein degraders, which offer advantages, such as specificity, stability and minimal off-site effects. Owing to these advantages and the ongoing pace of technological advancements, the targeted protein degradation market is poised to experience noteworthy growth during the forecast period.

Browse 185+ figures and 220+ market data tables spread across close to 450 pages and detailed Table of Content on “Targeted Protein Degradation Market Industry Trends and Global Forecasts, till 2035 by Type of Degrader (SERDs, PROTACs and Molecular Glues), Target Indication (Breast Cancer and Multiple Myeloma) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World)” here: https://www.rootsanalysis.com/reports/protein-degradation-market/289.html

Market Drivers

Several factors are contributing towards growth of the targeted protein degradation market. The increasing prevalence of cancer cases is driving the demand for targeted protein degradation therapies, consequently propelling market growth. Additionally, the ongoing pace of technological innovations in this field is likely to contribute towards the growth of the market. Further, majority of the targeted protein degradation therapies can be administered orally bolstering the demand for such therapies and eventually fueling the growth of this industry.

Market Restraints

While the targeted protein degradation market is experiencing a substantial activity, there are some factors that are restricting the growth of this industry. One of the primary restraints is the complex developmental process of these targeted protein degraders. Moreover, achieving targeted delivery of these agents poses another challenge, as they must effectively reach protein sites within cells to break down proteins, necessitating the optimization of drug delivery methods. Further, stringent control of the regulatory bodies, such as FDA in the US and EMA in Europe can result in prolonged launches, limited innovations and can even limit the ability of small businesses to effectively navigate the complexities of regulatory landscape.

Growth Factors

Despite the challenges, various growth factors continue to drive the targeted protein degradation market forward. One notable factor is the ability of targeted protein degraders to neutralize “undruggable” proteins. In fact, the existing inhibitors are able to bind to even less than 20% of all disease-causing proteins, leaving 80% of them as undruggable targets; therefore, presenting a lucrative opportunity for targeted protein degradation therapies. Further, the increasing partnership and investment activity is pivotal for accelerating the degrader discovery and research, indicative of future potential of the market.

Targeted Protein Degradation Therapies Market Segments

Based on the type of degrader, the market is segmented into SERDs, PROTACs and Molecular Glues

• The SERDs capture a 100% revenue share of the targeted protein degradation market, in 2024.
• The PROTACs are anticipated to be the fastest growing segments in this industry, growing at a rate of around 28%, till the year 2035.

Based on the target indication, the market is segmented into Breast Cancer and Multiple Myeloma

• The breast cancer targeting protein degradation therapies segment captures the 100% revenue share of the targeted protein degradation market, in 2024.
• The breast cancer targeting protein degradation therapies are anticipated to be the fastest growing segments in this industry, with annualized rate (CAGR) of around 30% during the forecast period.

Based on the Regional Insights, the market is segmented into North America, Europe, Asia Pacific and Rest of the World

• North America captures the largest revenue share of close to 85% in the market for targeted protein degradation in 2024.
• In Asia Pacific, the targeted protein degradation market is anticipated to demonstrate lucrative growth during the forecast period.

Key Companies Profiled

The targeted protein degradation market report also includes profiles of key players (listed below) that develops targeted protein degradation therapies:

• Arvinas
• AstraZeneca
• BeiGene
• Bristol-Myers Squibb
• C4 Therapeutics
• Eisai Therapeutics
• InnoCare Pharma
• Kangpu Biopharmaceuticals
• Kintor Pharmaceutical
• Loxo Oncology
• Medivir
• Monte Rosa Therapeutics
• Olema Oncology
• Radius Health
• Ranok Therapeutics
• Roche
• Sanofi
• Zentalis Pharmaceuticals

You Can Download Free Sample PDF Copy Of This Report At:
https://www.rootsanalysis.com/reports/protein-degradation-market/request-sample.html

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

Contact Details
Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com